Advertisement

High PLTP activity is associated with depressed left ventricular systolic function

      Abstract

      Phospholipid transfer protein (PLTP) modulates lipoprotein metabolism and plays an important role in inflammation and oxidative stress. High PLTP activity is associated with atherosclerosis and its risk factors, which also predispose to left ventricular systolic (LV) dysfunction and/or congestive heart failure. However there are few data linking PLTP activity directly to LV function. According, we sought to determine the relation between PLTP activity and LV ejection fraction (EF) in a Chinese cohort of 732 patients referred for coronary angiography. Weak but significant correlations of PLTP activity levels were found with age (r = −0.09, p = 0.017), male gender (r = 0.09, p = 0.019), diabetes (r = 0.08, p = 0.036), TG (r = 0.11, p = 0.003), HDL-C (r = −0.18, p = <0.001), apo A (−0.30, p < 0.001) apo B (r = 0.20, p < 0.001), fibrinogen (r = 0.32, p < 0.001) and LVEF (r = −0.12, p = 0.003). Median PLTP activity levels were higher among patients with reduced than in normal LV systolic function (LVEF <50%) [26.7 pmol/microl/h (IQR 20.2, 38.6) vs. 19.9 pmol/microl/h (IQR 12.2, 31.0), p < 0.001]. There was a step-wise increase in median PLTP levels in patients with normal, mild, and moderate-severe degrees of LV dysfunction (19.9 pmol/microl/h vs. 25.1 pmol/microl/h vs. 34.7 pmol/microl/h, p < 0.001). Median PLTP activity levels were higher among patients with unstable rather than stable AP and non-CHD patients (25.9 pmol/microl/h vs 20.2 vs 21.9, p = 0.012). On multivariate analyzes, higher median PLTP activity levels were associated with depressed LV systolic function as a dichotomous variable and with lower LVEF as a continuous variable. In conclusion, higher PLTP activity is associated with depressed LV systolic function in a dose-dependent manner independent of coronary heart disease as well as to unstable CHD.

      Highlights

      • Higher PLTP levels are associated with LV systolic function in a Chinese cohort.
      • PLTP levels increase in a step-wise manner with severity of LV dysfunction.
      • PLTP activity levels are higher among ACS than stable patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bruce C.
        • Beamer L.J.
        • Tall A.R.
        The implications of the structure of the bactericidal/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein.
        Curr Opin Struct Biol. 1998; 8: 426-434
        • Day J.R.
        • Albers J.J.
        • Lofton-Day C.E.
        • et al.
        Complete cDNA encoding human phospholipid transfer protein from human endothelial cells.
        J Biol Chem. 1994; 269: 9388-9391
        • Massey J.B.
        • Hickson D.
        • She H.S.
        • et al.
        Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteins.
        Biochim Biophys Acta. 1984; 794: 274-280
        • Erdmann J.
        • Grosshennig A.
        • Braund P.S.
        • et al.
        New susceptibility locus for coronary artery disease on chromosome 3q22.3.
        Nat Genet. 2009; 41: 280-282
        • McPherson R.
        • Pertsemlidis A.
        • Kavaslar N.
        • et al.
        A common allele on chromosome 9 associated with coronary heart disease.
        Science. 2007; 316: 1488-1491
        • Samani N.J.
        • Erdmann J.
        • Hall A.S.
        • et al.
        Genomewide association analysis of coronary artery disease.
        N Engl J Med. 2007; 357: 443-453
        • Willer C.J.
        • Sanna S.
        • Jackson A.U.
        • et al.
        Newly identified loci that influence lipid concentrations and risk of coronary artery disease.
        Nat Genet. 2008; 40: 161-169
        • Vergeer M.
        • Boekholdt S.M.
        • Sandhu M.S.
        • et al.
        Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility.
        Circulation. 2010; 122: 470-477
        • Kathiresan S.
        • Willer C.J.
        • Peloso G.M.
        • et al.
        Common variants at 30 loci contribute to polygenic dyslipidemia.
        Nat Genet. 2009; 41: 56-65
        • van Tol A.
        Phospholipid transfer protein.
        Curr Opin Lipidol. 2009; 13: 135-139
        • Schlitt A.
        • Bickel C.
        • Thumma P.
        • et al.
        High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease.
        Arterioscl Thromb Vasc Biol. 2003; 23: 1857-1862
        • Schgoer W.
        • Mueller T.
        • Jauhiainen M.
        • et al.
        Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis.
        Atherosclerosis. 2008; 196: 219-226
        • Desrumaux C.M.
        • Mak P.A.
        • Boisvert W.A.
        • et al.
        Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells.
        J Lipid Res. 2003; 44: 1453-1461
        • O'Brien K.D.
        • Vuletic S.
        • McDonald T.O.
        • et al.
        Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
        Circulation. 2003; 108: 270-274
        • Lee-Rueckert M.
        • Vikstedt R.
        • Metso J.
        • Ehnholm C.
        • Kovanen P.T.
        • Jauhiainen M.
        Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells.
        J Lipid Res. 2006; 47: 1725-1732
        • Laffitte B.A.
        • Joseph S.B.
        • Chen M.
        • et al.
        The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
        Mol Cell Biol. 2003; 23: 2182-2191
        • Tan K.C.
        • Shiu S.W.
        • Wong Y.
        • Tam S.
        Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus.
        Atherosclerosis. 2002; 178: 365-370
        • Cheung M.C.
        • Brown B.G.
        • Marino Larsen E.K.
        • Frutkin A.D.
        • O'Brien K.D.
        • Albers J.J.
        Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease.
        Biochim Biophys Acta. 2006; 1762: 131-137
        • Cheung M.C.
        • Vaisar T.
        • Han X.
        • Heinecke J.W.
        • Albers J.J.
        Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation.
        Biochem J. 2010; 49: 7314-7322
        • Vuletic S.
        • Taylor B.A.
        • Tofler G.H.
        • et al.
        SAA and PLTP activity in plasma of periodontal patients before and after full-mouth tooth extraction.
        Oral Dis. 2008; 14: 514-519
        • Cavusoglu E.
        • Marmur J.D.
        • Chhabra S.
        • Chopra V.
        • Eng C.
        • Jiang X.C.
        Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography.
        Atherosclerosis. 2009; 207: 261-265
        • Tall A.R.
        • Krumholz S.
        • Olivecrona T.
        • Deckelbaum R.J.
        Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis.
        J Lipid Res. 1985; 26: 842-851
        • Jauhiainen M.
        • Metso J.
        • Pahlman R.
        • Blomqvist S.
        • van Tol A.
        • Ehnholm C.
        Human plasma phospholipid transfer protein causes high density lipoprotein conversion.
        J Biol Chem. 1993; 268: 4032-4036
        • Yan D.
        • Navab M.
        • Bruce C.
        • Fogelman A.M.
        • Jiang X.C.
        PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity.
        J Lipid Res. 2004; 45: 1852-1858
        • Schlitt A.
        • Liu J.
        • Yan D.
        • Mondragon-Escorpizo M.
        • Norin A.J.
        • Jiang X.C.
        Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice.
        Biochim Biophys Acta. 2005; 1733: 187-191
        • Shelly L.
        • Roye L.
        • Sand T.
        • Jensen H.
        • Luo Y.
        Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice.
        J Lipid Res. 2008; 49: 773-781
        • Jiang X.C.
        • Tall A.R.
        • Qin S.
        • et al.
        Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E.
        J Biol Chem. 2002; 277: 31850-31856
        • Yang X.P.
        • Yan D.
        • Qiao C.
        • et al.
        Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.
        Arterioscler Thromb Vasc Biol. 2003; 23: 1601-1607
        • Samyn H.
        • Moerland M.
        • van Gent T.
        • et al.
        Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.
        Atherosclerosis. 2009; 204: 429-434
        • de Vries R.
        • Dallinga-Thie G.M.
        • Smit A.J.
        • Wolffenbuttel B.H.
        • van Tol A.
        • Dullaart R.P.
        Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
        Diabetologia. 2006; 49: 398-404